The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems

被引：0
|
作者：
Tricklebank, MD [1 ]
机构：
[1] MERCK SHARP & DOHME RES LABS, NEUROSCI RES CTR, HARLOW CM20 2QR, ESSEX, ENGLAND
来源：
BEHAVIOURAL BRAIN RESEARCH | 1996年 / 73卷 / 1-2期
关键词：
5-HT; dopamine; receptor subtype; mesolimbic; clozapine; schizophrenia;
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
Many neurochemical, electrophysiological and behavioural studies have shown how 5-HT and dopamine neuronal systems are able to interact and it is highly likely that the therapeutic benefits of clozapine-like atypical antipsychotic drugs are achieved by the modulation of such interactions. There are, however, at least fourteen subtypes of 5-HT receptor and five subtypes of dopamine receptor expressed in rodent and/or human brain and the optimum combination of receptor affinities required for maximum therapeutic benefit remains enigmatic.
引用
收藏
页码：15 / 17
页数：3
相关论文
共 50 条
  • [31] Erratum to: Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    Jean Reubi
    Beatrice Waser
    Jean-Claude Schaer
    Jean A. Laissue
    European Journal of Nuclear Medicine, 2001, 28 (9) : 1433 - 1433
  • [32] Advances in drug design and therapeutic potential of selective or multitarget 5-HT1A receptor ligands
    Giorgioni, Gianfabio
    Bonifazi, Alessandro
    Botticelli, Luca
    Cifani, Carlo
    Matteucci, Federica
    Di Bonaventura, Emanuela Micioni
    Di Bonaventura, Maria Vittoria Micioni
    Giannella, Mario
    Piergentili, Alessandro
    Piergentili, Alessia
    Quaglia, Wilma
    Del Bello, Fabio
    MEDICINAL RESEARCH REVIEWS, 2024, 44 (06) : 2640 - 2706
  • [33] 18F-labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor
    Hocke, Carsten
    Prante, Olaf
    Salama, Ismael
    Huebner, Harald
    Loeber, Stefan
    Kuwert, Torsten
    Gmeiner, Peter
    CHEMMEDCHEM, 2008, 3 (05) : 788 - 793
  • [34] THE 5-HT(1A) RECEPTOR SELECTIVE LIGANDS, (R)-8-OH-DPAT AND (S)-UH-301, DIFFERENTIALLY AFFECT THE ACTIVITY OF MIDBRAIN DOPAMINE NEURONS
    ARBORELIUS, L
    CHERGUI, K
    MURASE, S
    NOMIKOS, GG
    HOOK, BB
    CHOUVET, G
    HACKSELL, U
    SVENSSON, TH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 347 (04) : 353 - 362
  • [35] Electrostatic potential and non-covalent interactions analysis for the design of selective 5-HT7 ligands
    Rzesikowska, Katarzyna
    Krawczuk, Anna
    Kalinowska-Tluscik, Justyna
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2019, 91 : 130 - 139
  • [36] 5-HT3 ANTAGONISTS AND LIGANDS FOR DOPAMINE D1-RECEPTOR AND AUTORECEPTORS OFFER NEW LEADS FOR ANTIPSYCHOTIC-DRUGS
    ABBOTT, A
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (02) : 49 - 51
  • [37] Structure-Based Discovery of Selective Serotonin 5-HT1B Receptor Ligands
    Rodriguez, David
    Brea, Jose
    Isabel Loza, Maria
    Carlsson, Jens
    STRUCTURE, 2014, 22 (08) : 1140 - 1151
  • [38] Interactions of serotonin (5-HT)2c receptor-targeting ligands and nicotine:: locomotor activity and drug discrimination studies
    Zaniewska, M
    Filip, M
    McCreary, AC
    Wydra, K
    Nowak, E
    Przegalinski, E
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 308 - 309
  • [39] StructureActivity Relationships of Quinoxaline-Based 5-HT3A and 5-HT3AB Receptor-Selective Ligands
    Thompson, Andrew J.
    Verheij, Mark H. P.
    van Muijlwijk-Koezen, Jacqueline E.
    Lummis, Sarah C. R.
    Leurs, Rob
    de Esch, Iwan J. P.
    CHEMMEDCHEM, 2013, 8 (06) : 946 - 955
  • [40] Somatostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands (vol 28, pg 1433, 2001)
    Rebui, JC
    Waser, B
    Schaer, JC
    Laissue, JA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (09): : 1433 - 1433
12345